NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin)
- PMID: 3356698
NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin)
Abstract
Detailed investigations of a serum peptide (less than Glu1-Ala2-Lys3-Ser4-Gln5-Gly6-Gly7-Ser8-++ +Asn9) were carried out by 1H and 13C NMR spectroscopy to elucidate the structure of the complex formed with Zn(II), thymulin, which has been found to be active in vivo. These experiments were performed in dimethyl sulfoxide-d6 solution at different metal:peptide ratios. The results suggest the following conclusions. (i) The Zn(II) complexation corresponds to a fast exchange on the NMR time scale. (ii) The evolution of 1H and 13C NMR chemical shifts indicates the existence of two types of complexes: a 1:2 species associating two peptide molecules and one Zn(II) ion and a complex with 1:1 stoichiometry. The former is predominant for metal:peptide ratios below unity. (iii) In the 1:2 complex, Zn(II) is coordinated by the Ser4-O gamma H and Asn9-CO2- sites, while in the 1:1 complex, Ser8-O gamma H is the third ligand to the Zn(II) ion. The results are compared with those for the [Ala4] and [Ala8] analogues, and those for the complexes of thymulin with other metal ions (Cu2+ and Al3+) in terms of its biological activity. These comparative studies suggested that the 1:1 complex is the only conformation recognized by the antibodies.
Similar articles
-
Thymulin, a zinc-dependent hormone.Med Oncol Tumor Pharmacother. 1989;6(1):25-9. doi: 10.1007/BF02985220. Med Oncol Tumor Pharmacother. 1989. PMID: 2657247 Review.
-
Structural and conformational analysis of metal-containing peptides by one- and two-dimensional NMR spectroscopy. The case of thymulin.Mol Chem Neuropathol. 1990 Jan;12(1):37-54. doi: 10.1007/BF03160056. Mol Chem Neuropathol. 1990. PMID: 2278605
-
NMR study of thymulin, a lymphocyte differentiating thymic nonapeptide. Conformational states of free peptide in solution.J Biol Chem. 1986 Jun 15;261(17):7784-90. J Biol Chem. 1986. PMID: 3711109
-
Studies on the zinc binding site to the serum thymic factor.Biochim Biophys Acta. 1984 Feb 14;797(2):147-55. doi: 10.1016/0304-4165(84)90116-8. Biochim Biophys Acta. 1984. PMID: 6538097
-
Thymulin and the neuroendocrine system.Peptides. 2004 Jan;25(1):139-42. doi: 10.1016/j.peptides.2003.11.002. Peptides. 2004. PMID: 15003367 Review.
Cited by
-
The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.Ann N Y Acad Sci. 2009 Feb;1153:98-106. doi: 10.1111/j.1749-6632.2008.03964.x. Ann N Y Acad Sci. 2009. PMID: 19236333 Free PMC article. Review.
-
Thymulin, a zinc-dependent hormone.Med Oncol Tumor Pharmacother. 1989;6(1):25-9. doi: 10.1007/BF02985220. Med Oncol Tumor Pharmacother. 1989. PMID: 2657247 Review.
-
Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E182-7. doi: 10.1152/ajpendo.00085.2007. Epub 2007 Mar 27. Am J Physiol Endocrinol Metab. 2007. PMID: 17389714 Free PMC article.
-
Thymulin-based gene therapy and pituitary function in animal models of aging.Neuroimmunomodulation. 2011;18(5):350-6. doi: 10.1159/000329495. Epub 2011 Sep 22. Neuroimmunomodulation. 2011. PMID: 21952687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources